Recomendados
Recomendados
Más contenido relacionado
Similar a Gps Collaboration
Similar a Gps Collaboration (20)
Gps Collaboration
- 1. www.globalpharmas.com A Full Services Life Sciences ! Advisory Firm Serving the ! Pharmaceutical and Biotech industry!
- 3. Who we are. Delivering unique solu/ons for our global client partners, including organiza/on and sales force effec/veness, coaching and training, branding strategy, new market entry and business development through acquisi/on, sale, licensing and joint venture crea/on for pharmaceu/cal/biotechnology and healthcare consumer products. Privileged & Confiden/al
- 4. Who we are. Paul Ramirez, President and Managing Partner – 18+ years of pharmaceu/cal/biotech experience, US and global sales, marke/ng, opera/ons and business development (licensing and M&A) in branded prescrip/on, generic prescrip/on, and consumer healthcare businesses. Execu/ve at Schering‐Plough for 12‐years (1996‐2008); 4‐years GD Searle. AXorney; law prac/ce in New Jersey (1992‐1996). Alfredo M. Blanco, Vice President & Execu/ve Advisor – 50+ years in the pharmaceu/cal industry‐Respected industry leader/visionary. Most recently President of the La/n America and Far East Regions of Schering‐Plough, re/red in 2005. Leadership roles in La/n America, Africa, Middle East and Asia for Pfizer, GSK, GD Searle and Schering‐Plough. Cristobal Thompson, Partner & Director La/n America. Located in Mexico City, Mexico office. – 26+ years of commercial life sciences experience (17+ years in Mexico). Numerous leadership roles in the pharmaceu/cal, biotech and consumer/OTC industries in sales, marke/ng, market analy/cs and business development, both branded and generic products. Top management posi/ons in companies such as Colgate‐Palmolive, Quaker Oats, Stafford‐Miller, Schering‐Plough and Teva Pharmaceu/cals. Privileged & Confiden/al
- 5. Core Competencies A credible specialty life sciences consul/ng firm with nearly 100‐years experience in the La/n America and global pharmaceu/cal markets. Professional services delivered to global, regional and na/onal pharmaceu/cal and specialty biotech companies, drug delivery plagorm clients and life sciences venture capital firms. Privileged & Confiden/al
- 6. Core Competencies Business Development Licensing/business development exper/se in global pharmaceu/cal and OTC assets for placement in external markets. Connected to a global network of pharmaceu/cal asset resources and licensing professionals. Knowledge of the La/n America pharmaceu/cal and OTC markets, including government reimbursement formularies (i.e. IMSS etc.). Experienced in iden/fying relevant therapeu/c areas, high market poten/al molecules and unique/differen/ated delivery plagorms with intellectual property. Privileged & Confiden/al
- 7. Core Competencies Strategy, Organiza/on and Field Force Effec/veness Pharmaceu/cal and consumer healthcare exper/se in sales, brand marke/ng, organiza/onal design, field force effec/veness, strategic planning and business forecas/ng. KOL management, advisory board crea/on and key physician and ins/tu/on rela/onships. New business model analysis and crea/on. Privileged & Confiden/al
- 8. Core Competencies Current Projects‐ Represen/ng U.S. innovator in La/n America asset sale of recently FDA approved seda/ve hypno/c with delivery plagorm IP Represen/ng mul/‐na/onal drug delivery company in La/n America licensing of opioid TDD pain product Represen/ng U.S. specialty drug company in acquiring exclusive territory rights in La/n America for China bio‐similars and out‐ license within the territory Represen/ng U.S. specialty drug company in acquiring worldwide rights for systemic an/protozoal for Phase I clinical trial in relapsed or refractory neuroblastoma Privileged & Confiden/al
- 9. Core Competencies Representa1ve projects completed‐ • U.S. Commercial assessment of ANDA and 505(b)(2) introduc/on of inhaled cor/costeroid • Commercial and Regulatory considera/ons for introducing bio‐ similar drug products in Brazil and Mexico • Commercial market overview & organiza/onal assessment; Puerto Rico • Growing specialty pharmaceu/cal business in government healthcare programs; Puerto Rico • Federal and State legisla/ve strategy for respiratory product sales growth Privileged & Confiden/al
- 10. Business Development Model Research & Engage Iden1fy exci/ng late stage development or commercialized pharma/ biotech products Candidates have Asset differen/a/on of molecule or Represent delivery plagorm Search & Large pharmaceu/cal Licensee categories Engage Open care and specialty Engage asset owner Represent Asset Asset owner pays fees License asset in available territories Represent Asset (Licensor) Represent Licensee Companies seeking to enter or strengthen therapeu/c product porgolio The licensee is the client; licensee pays fees. Privileged & Confiden/al
- 11. Business Development Model Our research has idenNfied many non‐retained product opportuniNes awaiNng partners: PRODUCT OPPORTUNITY Examples: • Pain management (mul/ple) • Respiratory (mul/ple) • Cardiac imaging • Dermatology (mul/ple) • Probio/cs (Rx and OTC)‐mul/ple • Consumer (mul/ple) IP Protected: • NCEs • Novel Combina/ons • Unique Delivery Plagorms Privileged & Confiden/al
- 12. Our clients Privileged & Confiden/al
- 13. Current retained product licensing opportuniNes ‐Zolpimist™ (zolpidem tartrate) Oral Spray ‐Nitromist™ (nitroglycerin) Oral Spray Fentanyl Patch Licensed April 2009 Privileged & Confiden/al
- 14. Collabora/on Proposal • will partner with our client providing professional consul/ng services, as follows: • Licensing/business development – Seek high poten/al pharmaceu/cal assets worldwide for in‐license – Present product candidates and commercial opportunity – Approach asset owner – Facilitate deal to closure • Organiza/onal consul/ng, including sales, marke/ng, sales force maximiza/on/effec/veness. Privileged & Confiden/al
- 15. Collabora/on Proposal‐ Business Development 3 licensing phases: 1. Search and Iden/fy Quality Opportuni/es 2. Approach and Qualify the Opportunity 3. Nego/ate and Close the Opportunity Privileged & Confiden/al